Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.

By D. Herrington, D. Reboussin, K. Brosnihan, P. Sharp, S. Shumaker, Thomas E. Snyder, C. Furberg, Glen J. Kowalchuk, T. Stuckey, W. Rogers and 2 more. New England Journal of Medicine, 2000

1,286 citations recorded by the source corpus.

Subfields: Genetics

View Paper: https://www.semanticscholar.org/paper/2d1046bd3b4bd2c6e601d4d68471d63058f8a5d0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Sidney C. Smith
2. Joseph S. Alpert
3. A. Jacobs
4. E. Antman
5. L. Hiratzka
6. R. Gibbons
7. V. Fuster
8. J. Abrams

Citations in the corpus

• ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). (2003, background): “Thus, current information suggests that HRT in postmenopausal women does not reduce risk for major vascular events or coronary deaths in secondary prevention.”
• Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). (2002, result): “However, results of the Estrogen Replacement and Atherosclerosis trial suggest that unopposed estrogen is no more effective than estrogen plus medroxyprogesterone acetate.(21) Findings in the Women’s Estrogen for Stroke Trial,(22) which compared unopposed oral estradiol with placebo, mirrored the HE”
• Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study (2006, neutral): “was the Estrogen Replacement and Atherosclerosistrial.(15)Inthatstudy,309womenwith”